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Abstract
©  2017  Lomakin,  Arapidi,  Chernov,  Ziganshin,  Tcyganov,  Lyadova,  Butenko,  Osetrova,
Ponomarenko,  Telegin,  Govorun,  Gabibov  and  Belogurov.  Multiple  sclerosis  (MS)  is  an
autoimmune chronic inflammatory disease of the central nervous system (CNS). Cross-reactivity
of neuronal proteins with exogenous antigens is considered one of the possible mechanisms of
MS triggering.  Previously,  we  showed that  monoclonal  myelin  basic  protein  (MBP)-specific
antibodies from MS patients cross-react with Epstein-Barr virus (EBV) latent membrane protein 1
(LMP1). In this study, we report that exposure of mice to LMP1 results in induction of myelin-
reactive autoantibodies in vivo. We posit that chronic exposure or multiple acute exposures to
viral antigen may redirect B cells from production of antiviral antibodies to antibodies, specific
to myelin antigen. However, even in inbred animals, which are almost identical in terms of their
genomes, such an effect is only observed in 20-50% of animals, indicating that this change
occurs by chance, rather than systematically. Cross-immunoprecipitation analysis showed that
only part of anti-MBP antibodies from LMP1-immunized mice might simultaneously bind LMP1. In
contrast, the majority of anti-LMP1 antibodies from MBP-immunized mice bind MBP. De novo
sequencing  of  anti-LMP1  and  anti-MBP  antibodies  by  mass  spectrometry  demonstrated
enhanced clonal diversity in LMP1-immunized mice in comparison with MBP-immunized mice.
We suggest that induction of MBP-reactive antibodies in LMP1-immunized mice may be caused
by either Follicular dendritic cells (FDCs) or by T cells that are primed by myelin antigens
directly in CNS. Our findings help to elucidate the still enigmatic link between EBV infection and
MS development, suggesting that myelin-reactive antibodies raised as a response toward EBV
protein LMP1 are not truly cross-reactive but are primarily caused by epitope spreading.
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